Is there going to be a smoking cessation vaccine?

For many people, trying to quit smoking is one of the biggest challenges in their lives, due to the irresistible temptation of nicotine addiction in cigarettes. But researchers have found a way to make a new nicotine vaccine, which could help solve this problem.

Smokers who want to give up this bad habit now have very few tools in their hands, including patches and nicotine sweets, to try it. Moreover, these tools are not always effective.

The smoking cessation vaccine is designed to increase the amount of antibodies that bind to nicotine molecules, delaying the effects of nicotine on the human brain.(Photo: Corbis).

In addition to the above solutions, people who want to quit smoking can now also find nicotinic acetylcholine receptor attack drugs . However, according to scientific circles, these drugs often cause unpleasant side effects, including hallucinations, depression and mood swings.

Therefore, US researchers believe that vaccines that attack nicotine molecules may be an effective alternative. The team from Scripps Institute in California has developed a vaccine to reduce the effect of nicotine on the brain.

Specifically, the vaccine is designed to increase the amount of antibodies that bind to nicotine molecules, delaying the effects of nicotine. Unfortunately, two recent clinical trials of this new vaccine have failed.

However, the team confirmed that the tests provided them with clues on how to improve the effectiveness of smoking cessation vaccines. They found that those who produced the highest amount of anti-nicotine antibodies were more likely to stop smoking for more than 6 months.

Although there is still a lot of work to do, the initial research results raise the hope for the vaccine to help smokers officially launch in the near future.